Mycoses Clinical Trials

55 clinical trials for Mycoses across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Large Algorithm Setting and Validation Study — RECRUITING
• "No More Invisible! Playful Infection Prevention for Kindergarten - Kids" — RECRUITING
• Prospective Data Bank Creation to Study Vaginal Conditions — RECRUITING
• New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia — COMPLETED
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation — COMPLETED · PHASE3
• Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients — COMPLETED · NA
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections — COMPLETED · PHASE3
• A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects — COMPLETED · PHASE2
• Liver Transplant European Study Into the Prevention of Fungal Infection — COMPLETED · PHASE3
• Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis — COMPLETED · PHASE2
• Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma — COMPLETED · PHASE2
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis — COMPLETED · PHASE3
• Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) — COMPLETED · PHASE3
• Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites — COMPLETED · PHASE1
• A Study of Itraconazole in the Management of Superficial Fungal Infections in India — TERMINATED · PHASE4
• Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet — COMPLETED · NA
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension — COMPLETED · PHASE2
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections — COMPLETED · PHASE2
• Effect of Inflammation on Pharmacokinetics of Posaconazole — COMPLETED
• Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations — COMPLETED · PHASE4
• Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113) — OTHER
• Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization — COMPLETED
• Descriptive Epidemiology on Management of Mucormycosis — COMPLETED
• Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome — COMPLETED
• Bioequivalence Study for Terbinafine 250 mg — COMPLETED · PHASE1
• A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) — COMPLETED · PHASE2
• Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) — COMPLETED · PHASE3
• Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) — COMPLETED · PHASE3
• Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease — COMPLETED · PHASE3
• Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) — COMPLETED
• Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method — OTHER
• PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) — COMPLETED · PHASE2
• Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN) — WITHDRAWN
• Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641) — COMPLETED
• Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients — COMPLETED · PHASE4
• Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT — COMPLETED · PHASE4
• A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection — COMPLETED · PHASE3
• Voriconazole as Prophylaxis for Liver Transplant Recipients — COMPLETED
• Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients — OTHER · PHASE2
• Therapeutic Drug Monitoring of Voriconazole — COMPLETED · NA
• Pre-hospital Risk Factors for Invasive Fungal Infection — OTHER
• Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation — COMPLETED · PHASE4
• Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations — OTHER
• Voriconazole to Prevent Systemic Fungal Infections in Children — COMPLETED · PHASE1
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections — COMPLETED · PHASE3
• Voriconazole to Treat Fungal Infections — COMPLETED · PHASE3
• An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections — COMPLETED · PHASE3
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia — COMPLETED · PHASE1
• Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients — COMPLETED · PHASE3
• Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease — COMPLETED · PHASE2

Refine this search